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Abstract. The Kupffer (KCs) cells play the major role in the pathogenesis of chronic liver diseases, 
initiating and maintaining the inflammation and activation of the hepatic stellate cells (HSCs), events 
leading finally to liver parenchyma fibrosis and cirrhosis. The previous biodistribution studies showed 
an intense uptake of nanoparticles with specific characteristics and functional groups in the hepatic 
Kupffer (KCs), showing the major potential of these types of carriers for targeted therapy in liver 
inflammatory and storage disorders. In vivo uptake of Single and Multi-wall Carbon Nanotubes by the 
hepatic cells was tested, assessing the potential use of the ss-DNA-SWCNT as drug carriers for 
Kupffer cells targeted drug delivery. The changes in terms of histology, histochemistry and apoptosis 
were determined in liver in order to assess the local toxic effect. Fluorescently labeled Single Wall 
Carbon Nanotubes were injected intraperitoneally (IP) in rats and traced by CLSM and histology in 
terms of distribution and amount in the liver tissue. In the present experiment we determined the rapid 
and intense accumulation of both forms of CNT in Kupffer cells comparing with hepatocytes and 
endothelial cells, probing a strong and specific interaction of ss-DNA labeled nanoparticles with 
Kupffer cells. Discreet changes in the histology, histochemistry and caspase3 expression was 
observed. The strong Kupffer cell-associated nanoparticle distribution and the low toxicity at our 
tested dose open the possibilities of using this form of nanoparticle and functional group as 
nanocarriers for specific drug delivery in the hepatic Kupffer cells. 
 




 Kupffer cells (hepatic stellate macrophages) are fixed macrophages derived from the 
monocyte macrophage primes cells, playing an important role in the normal physiology and 
homeostasis of the liver. The Kupffer cells (KC) are the main cell in initiating and regulation 
of the inflammatory and repair responses in hepatic injures (pathogenesis of acute and chronic 
inflammatory liver diseases) (Jubb, 2007), in mediating the toxic hepatic effect of different 
compounds (Roberts, 2007) and responsible along hepatic Pitt cells (large granular 
lymphocytes fulfilling hepatic natural killer cells activity) with local antitumoral defense 
(Jubb, 2007; Roberts, 2007) as the main components of the hepatic innate immune response. 
In the normal rat liver KCs account approximately 15% of the total cell population, covering 
the entire mass of the hepatic tissue, with an increased density in the periportal areas of the 
hepatic lobules (Bouwens, 1986). In the hepatic lobules KCs arelocated in the proximity of 
the capillaries, lining the inner part of the hepatic capillaries (attached to the sinusoidal wall-
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sinusoidal endothelial cells) in direct contact with the blood (Jubb, 2007), location which 
facilitate their main role-removing particles from the blood-stream and detoxification (eg. 
xenobiotics, etanol, etc). Kupffer cells in both normal and pathology situations can easily 
relocate and cross the sinusoidal wall in Disse space (MacPhee, 1992) interacting directly or 
by mediation of chemical signals (cytokines, reactive oxygen and nitrogen species, etc) with 
the Ito cells (hepatic  stellate cells), hepatocytes, hepatic oval cells and also with the 
extracellular matrix (Kolios, 2006). Because of their multiple role and complex interaction 
with the stromal and parenchymal cells, KC are involved in all main acute and chronic 
pathologies of the liver: hepatic fibrosis and cirrhosis (Rockey, 2012), infectious (Barsig, 
1998) and toxic hepatitis (including alcohol-related liver injuries and non alcoholic 
steatohepatitis) (Cubero, 2006), chosestasis (Schmid, 1965), metastatic and primary-hepatic 
tumors as hepatocellular carcinoma (Hagen, 1994), etc.  
 Due to this role in the liver pathologies, KC are the subject of the strategies for 
hepatic-targeting therapies or recently to Kupffer cell targeted therapy. This targeted therapy 
is mediated through adenoviral vectors (Xu, 2008), coating the active molecule with coupled 
to albumin (Schreier, 2001), mannosylated albumin (Melgert, 2001), or by nanoparticles coated 
with diffrent functional groups (Wu, 2009). 
 In this study we investigated the possible utilization of Single Wall Carbon Nanotubes 
(SWCNT) as drug carriers for Kupffer cells targeted drug delivery. 
 
MATERIALS AND METHODS    
 
Carbon Nanotubes. The synthesis of the Single-Walled Carbon Naotubes used in this 
experiment was performed by the catalytic chemical vapor deposition method using the co-
precipitation of the Fe:Mo:MgO catalyst (Biris, 2006). The detailed synthesis of the nano-material 
and functionalization procedure was previously described by Simon et al. (Simon, 2009). 
Experiment design. The experimental was carried out on 36 male Wistar strain rats. 
The animals were divided in 3 equal lots (SWCNT group harvested at 24h, SWCNT group 
harvested at 48 h and reference group). The SWCNT administration was performed 
intraperitoneallyn a single dose of 1.5 ml/ animal. The reference group received 
intraperitoneally 1.5 ml of sterile saline solution (PBS). More details regarding the protocol 
design, SWNT-DNA concentration and gathering of the tissue samples during necropsy can 
be consulted in our previous publications (Simon, 2009; Tabaran, 2011). 
Histopathologic examination. The tissue specimens harvested during necropsy were 
fixed in buffered formalin (10%), and embedded in paraffin wax following the routine 
protocol. The tissue was stained using Hematoxylin-Eosin (HE), Periodic acid-Schiff (PAS) 
and Perls-Prussian blue methods.  
Confocal Laser Scanning Microscopy . Tissue samples from liver were analyzed using 
a Zeiss LSM 710 Confocal Laser Scanning equipped with Argon and HeNe lasers. The laser 
lines used for CLSM were: for Cy3, excitation 633 nm and 547–629 nm and emission filters, 
and for DRAQ5 543 nm excitation and 661–757 nm emission filters (BMP splitter 
488/543/633). Images were recorded using a Zeiss Plan Apochromat 63× (1.4; oil immersion, 
DIC 27) objective. Details of the CLSM technique and microscope settings used in this 
experiment can be consulted in our previous publication (Tabaran, 2010). 
Immunohistochemestry. For identification of KCs we used the immunohistochemical 
expression of the CD68. The immunohistochemical reaction was performed using the Leica 
Bond-Max 
TM 
unit, folowing the standard indirect avidin-biotin reaction. The primary antibody 




RESULTS AND DISCUSSIONS 
 
Histochemical differentiation of carbon nanotubes from endogenous pigments 
In terms of identification, SWCNT accumulated in Kupffer cells as dark brown 
granules on hematoxylin-eosin staining, property that is kept on both Perls and PAS stains 
(Fig. 1). No significant changes were observed in the liver except pigment accumulations.  
However, 24 hours after the nanotubes administration isolated hepatocytes undergoing 
apoptosis were observed (2-3 cells per hepatic lobule).These cells showed intense 
eosinophilic cytoplasm, with angular outline and hyperchrome nucleic. Apoptic bodies were 
rarely observed.  Although apoptosis can be spontaneously observed in the liver, direct 
stimulation by specific xenobiotics can trigger pro-apoptotic pathways in hepatocytes 




Fig. 1 Histochemical differentiation of SWCNT (arrows) from the endogenous pigments in liver.  
The arrows indicate the nanoparticle accumulations as blackish bulks in the KCs.  
The nanomaterials are negative at PAS stain (center column) and to the Perls reaction (right column). 
The star marks a hepatocyte undergoing individual cell necrosis/apoptosis; obx100. 
 
Confocal lasser scanning microscopy identification of SWCNT 
The cy3 fluorescence of the carbon nanotubes was observed in the liver parenchima for 
all the animals which received fluorescently labeled SWCNT without important differences in 
terms of distribution and with discrete changes in terms of quantity. Carbon nanotubes were 
detected mainly in the KCs, without noticeable accumulation in hepatocytes or in the liver 
tissue interstitium (Fig. 2). The observation of SWCNT in CLSM overlaps with the conclusions 
drawn from the histological examination- the identified nanotubes have similar locations, 
mainly in the KCs, using both CLSM and histological tehniques. The KCs are are the main 
structures responsible for the removal of particles, including nanoparticles from the organism 
(Sadauskas 2007). The interaction on KC with circulating particles is the expression of a 
phylogenetically well conserved function of these cells. As a innate immune response the 
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clearance of particle by KCs is mediated by the scavenger receptors (ex. CD68), by the 




Fig. 2 Confocal lasser scanning microscopy identification of cy3-SWCNT in the liver tissue.  
The cy3 fluorescence can be visualized on the green channel. The red fluorescence corresponds to the 
DRAQ5 staining of the nuclei. A- Ortho display of a z-scan area of the liver proving the intracellular 
presence of SWCNT in the sinusoidal KC. B-Fluorescence profile of image A on the axis 1. C-
Detailed fluorescence of the axis 1 prooving the specific Cy3 fluorescence peaks in the scanned area. 
The pointed line represents the arbitrary line of autofluorescence for the green channel. 
 
 
But this interaction is more complex considering the fact that in vitro KCs mentain 
their function regarding particle uptake, engulfing nanoparticles without previous 
opsonisation or coating. Because of this function many strategies were adopted for 
avoiding this uptake and elude the surveillance of the monocyto-macrophage system in 
particular the KCs and as a consequence to increase the biomolecule half time and to 
maintain a long-time therapeutic concentration. This strategies include modification of the 
particle surface (ex.coating the NP with polyethylene-glycol, polystyrene) (Storm, 1995) 
or synthesizing nanoparticles with size under of 4-6 nm (Sadauskas, 2007), the 
characteristics of the nanopartile surface and size being the two major determinants for the 






Fig. 3 Immunohistochemical identification of KCs using the CD68 antigen.  
The carbon nanotubes  are observed as black bulks inside the immunolabeled KCs; obx 40. 
 
Although in this study we observed intense accumulation of SWCNT-DNA in the 
KCs, this is an expected observation due to the fact that most of circulating nanoparticles are 
engulfed in this cells from the liver and in the fixed macrophages from the spleen. Surprising 
is the reduced toxicity of these nanoparticles in this short-time study. Long-term toxicity 
studies will be performed and the results will complete the conclusions of this study, 
completing the image of the liver toxicity of these nanoparticles. The discrete reaction of the 
hepatic tissue following SWCNT accumulation provide us arguments for further application 




Single walled carbon nanotubes accumulate rapidly in the Kupffer cells after 
intraperitoneal administration, keeping their location and distribution in the liver unchanged 
throughout the experiment. The important Kupffer cell-associated nanoparticle distribution, 
accumulation, and low acute toxicity open the possibility for using SWCNT-DNA as potential 
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